James E. Fickenscher, Senior Vice President & CFO at ANTARES PHARMA, INC. (ATRS), bought 40,000 shares at $2.50 ($100K) on 2014-12-11, disclosed to the SEC on 2014-12-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| ZYNE | SELL | 2022-07-20 | $7K | — | Filing → |
| ZYNE | BUY | 2018-08-07 | $102K | — | Filing → |
| ZYNE | BUY | 2017-05-16 | $103K | — | Filing → |